Share-based Payment Arrangement, Expense in USD of Telesis Bio Inc. from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Telesis Bio Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q2 2020 to Q3 2024.
  • Telesis Bio Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2024 was $566K, a 51% decline year-over-year.
  • Telesis Bio Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2024 was $2.82M, a 39.3% decline year-over-year.
  • Telesis Bio Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.96M, a 6.33% increase from 2022.
  • Telesis Bio Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.73M, a 243% increase from 2021.
  • Telesis Bio Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.09M, a 2426% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Telesis Bio Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.82M $566K -$590K -51% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $3.41M $869K -$166K -16% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $3.57M $766K -$390K -33.7% 01 Jan 2024 31 Mar 2024 10-Q 10 May 2024
Q4 2023 $3.96M $616K -$678K -52.4% 01 Oct 2023 31 Dec 2023 10-K 29 Mar 2024
Q3 2023 $4.64M $1.16M +$241K +26.3% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 $4.4M $1.04M -$83K -7.42% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $4.48M $1.16M +$756K +189% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024
Q4 2022 $3.73M $1.29M +$808K +166% 01 Oct 2022 31 Dec 2022 10-K 29 Mar 2024
Q3 2022 $2.92M $915K +$515K +129% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 $2.4M $1.12M +$1.02M +1018% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023
Q1 2022 $1.39M $400K +$300K +300% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 $1.09M $486K 01 Oct 2021 31 Dec 2021 10-K 22 Mar 2023
Q3 2021 $400K +$300K +300% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 $100K +$90K +900% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022
Q1 2021 $100K 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q3 2020 $100K 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $10K 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021

Telesis Bio Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.96M +$236K +6.33% 01 Jan 2023 31 Dec 2023 10-K 29 Mar 2024
2022 $3.73M +$2.64M +243% 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024
2021 $1.09M +$1.04M +2426% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2023
2020 $43K 01 Jan 2020 31 Dec 2020 10-K 23 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.